Good Faith Exam
for Tirzepatide

$26.99 Per Exam

Nurse-Owned and Clinician-Led

Nationwide Coverage

Independent Medical Judgment

For Startups

For Established Practices

Tirzepatide delivers strong clinical outcomes. It also carries a specific contraindication profile that requires a careful evaluation before it is prescribed. A good faith exam for tirzepatide is that evaluation. It is a documented medical review conducted by a licensed physician before the prescription is written.
GoodFaithExams.com delivers that review online so practices prescribe with confidence and every patient starts treatment on a proper clinical foundation.

What Is a Good Faith Exam for Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist. That dual mechanism makes it one of the most effective weight loss medications currently available. It is also a prescription drug with a contraindication profile that requires clinical review before it is prescribed.

A good faith exam for tirzepatide is a medical evaluation conducted by a licensed physician before the medication is prescribed. The physician reviews the patient’s health history, current medications, metabolic and endocrine conditions, cardiovascular risk, and contraindications specific to this drug class.


Key contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, prior pancreatitis, significant gastrointestinal conditions, and concurrent hypoglycemic medications. These are the clinical factors the evaluation identifies before a prescription is written.


Tirzepatide good faith exam documentation establishes the clinical record that supports every prescribing decision. GoodFaithExams.com delivers that documentation online without disrupting the workflow.

Why Tirzepatide GFE Requirements Exist

Tirzepatide is in the same regulatory category as semaglutide. The prescribing standard requires a valid patient-provider relationship and a documented clinical evaluation before the medication is issued.
Tirzepatide GFE requirements exist because this medication’s rapid adoption has created the same compliance pressures already seen across the broader GLP-1 category. A documented good faith exam demonstrates a licensed provider evaluated this patient for this specific medication before prescribing began.

Who Can Perform It

The provider must hold prescribing authority and be licensed within scope. Qualified providers include physicians, nurse practitioners with prescribing authority and appropriate supervision agreements, and physician assistants with prescribing authority and appropriate supervision agreements.
GoodFaithExams.com connects patients with licensed physicians meeting state-specific requirements.

What to Expect

Patient Intake

Patients submit health history, current medications, metabolic and endocrine history, and the formulation being considered.

Provider Evaluation

A licensed physician reviews the case.

Clinical Decision

The provider approves, modifies, or declines based on independent clinical judgment.

Documented Outcome

Each evaluation is recorded and delivered to the practice.

How GoodFaithExams.com Makes It Simple

An online GFE for tirzepatide through GoodFaithExams.com is built for active prescribing operations.
Available Monday Through Sunday. No scheduling windows.
A good faith evaluation for tirzepatide on GoodFaithExams.com covers thyroid and endocrine history, pancreatic history, cardiovascular risk factors, and medication interactions relevant to this drug class. Not a generic clearance.
A telehealth good faith exam for tirzepatide is conducted by a licensed physician reviewing each patient individually. No automated approvals. Every finding documented.

Pricing

$26.99 per exam.

No hidden fees. No monthly minimums. No contracts.

Who This Is and Is Not For

Good fit:

Not for:

Ready to Get Started

Tirzepatide delivers results for the right patients. A good faith exam for tirzepatide through GoodFaithExams.com makes sure every prescription starts with the right evaluation. Fast, affordable, and defensible.
Start today at GoodFaithExams.com.

Frequently Asked Questions

How is tirzepatide different from semaglutide and does that affect the evaluation?

Tirzepatide targets both GIP and GLP-1 receptors, which produces stronger weight loss outcomes than single-mechanism GLP-1 agents in most patients. The contraindication profile overlaps with semaglutide but the dual mechanism and interaction considerations differ. A prior semaglutide evaluation does not substitute for a tirzepatide-specific review.
A good faith exam for tirzepatide is a required medical evaluation conducted by a licensed physician before a tirzepatide prescription is issued. It reviews health history, current medications, and contraindications specific to dual GIP and GLP-1 receptor agonists, and establishes the patient-provider relationship required before prescribing begins.
Tirzepatide GFE requirements specify that a licensed provider with prescribing authority must conduct a documented clinical evaluation before tirzepatide is prescribed. The core standard is consistent across states. Provider type requirements and supervision structures vary by jurisdiction.
The dual receptor mechanism of tirzepatide means the reviewing physician considers both GIP and GLP-1 interaction profiles. Thyroid history, endocrine conditions, pancreatic history, cardiovascular risk, and concurrent hypoglycemic medications are all reviewed in the context of a medication that is more potent than single-mechanism alternatives.
Yes. The evaluation requirement applies to tirzepatide prescribing regardless of formulation. Mounjaro, Zepbound, and compounded tirzepatide all fall under the same prescribing standard.
It is the clinical process through which a licensed physician assesses a patient’s individual suitability for tirzepatide therapy, reviews contraindications specific to this drug class, and documents an independent decision before the prescription is written. It is not a sign-off. It is a clinical record.
Good faith exam telemedicine for tirzepatide is the completion of a pre-prescribing clinical evaluation through a remote digital platform. GoodFaithExams.com provides this through licensed physicians who review every patient individually and document clinical decisions before tirzepatide is prescribed.
The patient submits health history, current medications, metabolic and endocrine information, and the formulation being considered. A licensed physician reviews the case and documents independent clinical findings. The practice receives the completed record with no coordination required on their end.
A tirzepatide GFE provider must be a licensed physician, nurse practitioner, or physician assistant with prescribing authority, operating within scope and meeting the state supervision and licensing requirements where the patient is located. GoodFaithExams.com uses only licensed physicians on the platform.
It creates a documented record showing a licensed physician reviewed the patient’s profile, assessed the dual receptor contraindication profile, and made an independent prescribing decision before the prescription was issued. That record is what medical boards and federal investigators examine when reviewing prescribing practices in this category.

Book Your Spot Today

No pressure. No pitch. Just 15 minutes to see exactly how it works for your practice

$26.99

Per Exam

All 50

States Covered

Mon–Sun

Always Open

Zero

Contracts

Start Your Free
Good Faith Exam Trial

Nurse-owned. Licensed in all 50 states. Independent medical judgment on every exam.
STEP 1 OF 2

What type of clinic do you operate?

Medspa/Aesthetics

Weight Loss

IV/Wellness

Telehealth

Hormone Therapy

Other

STEP 2 OF 2

Almost there. Tell us about your practice.

I want to change my clinic type

You're on your way!

We received your request for a physician.
Our team will contact you soon.

$26.99

Per Exam

All 50

States Covered

Mon–Sun

Always Open

Zero

Contracts